Glucocorticoids for treating paediatric pulmonary hypertension: a novel use for a common medication

Cardiology in the Young
Manish Aggarwal, Ronald Mark Grady

Abstract

Laboratory investigations have shown the role of inflammation in the pathogenesis of pulmonary hypertension and improvement after anti-inflammatory drugs. Despite these observations, reports on the use of steroids to treat pulmonary hypertension in humans are absent from the literature. In this article, we report the use of glucocorticoids in the treatment of two children with pulmonary hypertension, demonstrating its potential utility.

Associated Clinical Trials

References

Aug 10, 2010·The European Respiratory Journal·L C PriceF Perros
Jan 5, 2011·American Journal of Respiratory and Critical Care Medicine·Aiko OgawaHiroshi Ito
Jan 5, 2012·Chest·Laura C PriceMarc Humbert
Dec 21, 2013·Journal of the American College of Cardiology·Gerald SimonneauRogiero Souza
Mar 4, 2014·The European Respiratory Journal·Paul M Hassoun

❮ Previous
Next ❯

Citations

Feb 22, 2018·Current Treatment Options in Cardiovascular Medicine·Manish Aggarwal, R Mark Grady
Jan 27, 2019·Cardiology in the Young·Manish AggarwalR Mark Grady

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here